What are the treatment regimens and doses for bacterial, viral, and fungal meningitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Meningitis: Dosing Regimens

Bacterial Meningitis

For empiric treatment of bacterial meningitis in adults, administer ceftriaxone 2g IV every 12 hours (total 4g daily), with the addition of vancomycin 15-20 mg/kg IV every 12 hours if penicillin-resistant pneumococci is suspected, and add amoxicillin 2g IV every 4 hours for patients ≥60 years old to cover Listeria monocytogenes. 1

Empiric Therapy Algorithm

Age-based approach:

  • Adults <60 years: Ceftriaxone 2g IV every 12 hours OR cefotaxime 2g IV every 6 hours 1
  • Adults ≥60 years: Same cephalosporin regimen PLUS amoxicillin 2g IV every 4 hours 1
  • Add vancomycin 15-20 mg/kg IV every 12 hours (targeting trough levels 15-20 μg/mL) OR rifampicin 600mg twice daily if penicillin-resistant pneumococci suspected (recent travel to high-resistance areas) 1

Alternative if cephalosporins contraindicated:

  • Adults <60 years: Chloramphenicol 25 mg/kg IV every 6 hours 1
  • Adults ≥60 years: Chloramphenicol 25 mg/kg IV every 6 hours PLUS co-trimoxazole 10-20 mg/kg (trimethoprim component) in four divided doses 1

Pathogen-Specific Therapy

Once organism identified, tailor therapy:

Streptococcus pneumoniae:

  • Penicillin-sensitive: Benzylpenicillin 2.4g IV every 4 hours OR continue ceftriaxone 2g IV every 12 hours 2, 1
  • Penicillin-resistant but cephalosporin-sensitive: Continue ceftriaxone 2g IV every 12 hours OR cefotaxime 2g IV every 6 hours 2, 1
  • Penicillin AND cephalosporin-resistant: Ceftriaxone or cefotaxime PLUS vancomycin PLUS rifampin 600mg twice daily 2
  • Duration: 10-14 days (10 days if recovered by day 10; extend to 14 days if not recovered or if resistant organism) 2, 1

Neisseria meningitidis:

  • Ceftriaxone 2g IV every 12 hours OR cefotaxime 2g IV every 6 hours 1
  • Alternative: Benzylpenicillin 2.4g IV every 4 hours 1
  • Duration: 5-7 days 3, 1

Haemophilus influenzae:

  • Ceftriaxone 2g IV every 12 hours 3
  • Duration: 10 days 3

Listeria monocytogenes:

  • Amoxicillin 2g IV every 4 hours (already included in empiric regimen for ≥60 years) 1
  • Duration: 21 days 3

Enterobacteriaceae:

  • Ceftriaxone 2g IV every 12 hours 3
  • Duration: 21 days 3

Staphylococcal species:

  • MSSA: Nafcillin or oxacillin; alternatives include vancomycin or meropenem 2
  • MRSA: Vancomycin 15-20 mg/kg IV every 12 hours, consider adding rifampin 600mg IV/orally every 12 hours 2
  • Duration: 14 days 2

Post-Neurosurgical Meningitis

Empiric regimen: Vancomycin 15-20 mg/kg IV every 12 hours PLUS one of the following: 2

  • Ceftazidime 2g IV every 6 hours, OR
  • Cefepime 2g IV every 8 hours, OR
  • Meropenem 2g IV every 8 hours

Duration: 10-14 days for uncomplicated cases with good clinical response; extend if delayed response 2

Critical consideration: If CSF shunt present and infected, remove all shunt components in addition to antimicrobial therapy 2

Pediatric Dosing

Meningitis: Initial dose 100 mg/kg ceftriaxone (maximum 4g), then 100 mg/kg/day (maximum 4g daily) given once daily or divided every 12 hours 4

Duration: 7-14 days typically 4

Neonates (22-60 days): Ceftriaxone 50 mg/kg once daily for bacteremia/UTI; avoid ceftriaxone for neonatal meningitis 22-28 days—use ampicillin plus ceftazidime every 8 hours instead 3

Critical caveat: Administer IV doses over 60 minutes in neonates to reduce bilirubin encephalopathy risk 4

Important Clinical Considerations

Dosing frequency matters for CNS penetration: While once-daily ceftriaxone dosing has been studied and shows efficacy 5, 6, current guidelines uniformly recommend twice-daily dosing (2g every 12 hours) for the first 24-48 hours to ensure rapid CSF sterilization and adequate concentrations throughout the dosing interval 3. After clinical improvement and organism susceptibility confirmed, some institutions reduce to once-daily dosing 7.

Monitoring parameters:

  • Clinical response daily: fever, neck stiffness, mental status 1
  • Vancomycin trough levels: maintain 15-20 μg/mL 1
  • Consider repeat CSF analysis if no improvement after 48-72 hours 1

Administration pitfalls to avoid:

  • Never mix ceftriaxone with calcium-containing solutions—can cause fatal precipitation 4
  • Vancomycin must be infused over ≥60 minutes to avoid infusion reactions 1
  • In neonates, ceftriaxone infusion must be over 60 minutes 4

Viral Meningitis

Viral meningitis is typically self-limited and requires supportive care only. Specific antiviral therapy is reserved for:

Herpes simplex virus (HSV) meningitis/encephalitis:

  • Acyclovir 10 mg/kg IV every 8 hours for 14-21 days (based on general medical knowledge)

Varicella-zoster virus (VZV):

  • Acyclovir 10-15 mg/kg IV every 8 hours for 10-14 days (based on general medical knowledge)

Fungal Meningitis

Cryptococcal meningitis (most common fungal cause):

  • Induction: Liposomal amphotericin B 3-4 mg/kg/day IV PLUS flucytosine 100 mg/kg/day divided every 6 hours for ≥2 weeks (based on general medical knowledge)
  • Consolidation: Fluconazole 400-800 mg daily for 8 weeks (based on general medical knowledge)
  • Maintenance: Fluconazole 200 mg daily for ≥1 year (based on general medical knowledge)

Candida meningitis:

  • Liposomal amphotericin B 5 mg/kg/day IV PLUS flucytosine 100 mg/kg/day divided every 6 hours (based on general medical knowledge)

References

Guideline

Antibiotic Treatment for Bacterial Meningitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Antibiotic Regimens for Post-Neurosurgical Meningitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Ceftriaxone Dosing Recommendations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

A single daily dose of ceftriaxone for bacterial meningitis in adults: experience with 84 patients and review of the literature.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1995

Research

Treatment of bacterial meningitis with once daily ceftriaxone therapy.

The Journal of antimicrobial chemotherapy, 1988

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.